The Pharma Stock That Just Doubled

Several Fed speakers could weigh in on the recent batch of ugly economic data

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

OPENING VIEW     2/22/2019
There are Still Unknown Pot Stocks! Most of the "big names" in marijuana are so overvalued there can be only downside for long term investors. Meanwhile small cannabis firms are quietly building their own powerhouses and have yet to be discovered. Get in now, before Wall Street catches on!
Dow Futures Get a Lift on Trade Optimism By Lillian Currens Share On Dow Jones Industrial Average (DJI) futures are up over 100 points today, on hopes that a trade resolution between the U.S. and China is in sight. Ahead of the March 1 tariff deadline, and after weeks of lower-level trade talks, President Donald Trump and Chinese Vice Premier Liu He will meet in Washington, D.C., today. Elsewhere, Wall Street looks ahead to a number of speeches from Fed leaders, who could weigh in on the recent batch of ugly economic data. Continue reading for more on today's market, including:  The drug stock that just doubled.   What this bearish trendline could mean for Mylan before earnings.  Behind the worst day in years for this pizza stock.  Plus, Wayfair soars on an earnings beat; Citigroup stock gets a good review; and Roku shares a sunny forecast.  >> Continue reading...
LATEST HEADLINES
>> The Future of the Trillion-Dollar "Green Tech" Movement As more millennials are interested in sustainable investments, one "green tech" company is leading the charge on clean drilling. >> Stocks Cool Off, Nasdaq Streak Snapped Reports are circulating that the U.S. and China are seemingly nearing a trade agreement >> The Volatility Prediction Tool with 77.6% Accuracy A free tool can help traders bank big during the upcoming earnings season. >> EpiPen Producer Nears Historically Bearish Trendline However, call buyers are active ahead of earnings next week >> Zosano Pharma Scales Nasdaq on Migraine Drug Data A major price-target from BTIG is also creating tailwinds for ZSAN stock ADVERTISEMENT The Warren Buffett Weed Play? One Company is Following Warren's Formula, and Investors Could Reap Berkshire Returns, don't miss out on the next big cannabis stock
To ensure delivery of Schaeffer's Opening View, add us to your contacts! For more information, please visit this link for further instructions. This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Opening View or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Opening View? You can unsubscribe here. For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions. Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
		SCHAEFFER'S OPENING VIEW enews@schaeffer.com 5151 Pfeiffer Rd. Suite 250 Cincinnati, OH, 45242 USA 800-448-2080 www.schaeffersresearch.com